We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$39.9B
AUM Growth
+$891M
(+2.3%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$171M |
| 2 |
Sensata Technologies
ST
|
+$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$133M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
AbbVie
ABBV
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$164M |
| 2 |
Ross Stores
ROST
|
+$110M |
| 3 |
Bank of America
BAC
|
+$94.4M |
| 4 |
Freeport-McMoran
FCX
|
+$92.4M |
| 5 |
Five Below
FIVE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.1% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Lamar Advertising Co
LAMR
$16.3B
| $21.8M | 0.05% |
330,000
+58,433
| +22% | +$3.88M |
|
352
ProQR Therapeutics
PRQR
$265M
| $21.8M | 0.05% |
4,550,062
| – | – |
|
353
Kraft Heinz
KHC
$30B
| $21.7M | 0.05% |
724,332
+4,700
| +0.7% | +$156K |
|
354
Weyerhaeuser
WY
$18.4B
| $21.7M | 0.05% |
760,549
-82,351
| -10% | -$2.26M |
|
355
Delta Air Lines
DAL
$60.1B
| $21.6M | 0.05% |
707,311
+51,500
| +8% | +$1.49M |
|
356
GCM Grosvenor
GCMG
$820M
| $21.6M | 0.05% |
+2,075,000
| New | +$21.9M |
|
357
Entergy
ETR
$50B
| $21.5M | 0.05% |
435,502
-14,600
| -3% | -$723K |
|
358
Spyre Therapeutics
SYRE
$9.25B
| $21.2M | 0.05% |
119,680
+4,000
| +3% | +$740K |
|
359
Vale
VALE
$62.6B
| $21.2M | 0.05% |
2,000,000
-1,000,000
| -33% | -$11.2M |
|
|
PXD
360
DELISTED
Pioneer Natural Resource Co.
PXD
| $21.1M | 0.05% |
245,430
+60,607
| +33% | +$5.97M |
|
361
Skyworks Solutions
SWKS
$10.6B
| $21.1M | 0.05% |
144,850
-16,900
| -10% | -$2.35M |
|
|
CHMA
362
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $21.1M | 0.05% |
4,900,000
+2,000,000
| +69% | +$9.58M |
|
|
INZY
363
DELISTED
Inozyme Pharma
INZY
| $21M | 0.05% |
+800,000
| New | +$19.9M |
|
364
Halozyme
HALO
$12.2B
| $21M | 0.05% |
800,000
-200,000
| -20% | -$5.57M |
|
365
Boston Properties
BXP
$11.1B
| $21M | 0.05% |
261,789
+86,871
| +50% | +$7.58M |
|
366
Take-Two Interactive
TTWO
$46.1B
| $21M | 0.05% |
127,170
-4,464
| -3% | -$725K |
|
367
Alexandria Real Estate Equities
ARE
$8.56B
| $21M | 0.05% |
131,100
-14,700
| -10% | -$2.45M |
|
368
Simon Property Group
SPG
$72.3B
| $20.9M | 0.05% |
+323,904
| New | +$21.2M |
|
|
HZAC.U
369
DELISTED
Horizon Acquisition Corporation Units, each consisting of one Class A ordinary share and one-third o
HZAC.U
| $20.8M | 0.05% |
+2,000,000
| New | +$20.5M |
|
370
Donaldson
DCI
$11.4B
| $20.8M | 0.05% |
447,787
-437,637
| -49% | -$21.3M |
|
371
Williams Companies
WMB
$86.1B
| $20.7M | 0.05% |
1,051,899
+581,000
| +123% | +$11.8M |
|
372
Labcorp
LH
$25.9B
| $20.7M | 0.05% |
127,691
-52,613
| -29% | -$8.34M |
|
373
ConocoPhillips
COP
$141B
| $20.6M | 0.05% |
626,692
-723,700
| -54% | -$27.4M |
|
374
MarketAxess Holdings
MKTX
$5.72B
| $20.4M | 0.05% |
42,450
-1,400
| -3% | -$692K |
|
375
American Electric Power
AEP
$68.4B
| $20.4M | 0.05% |
249,750
-310,000
| -55% | -$25.5M |
|
Similar funds
Adage Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.
- Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
- Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
- Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
- Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
- Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
- Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
- Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.
Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.